ATS Corp. (ATS) gave back 14% on its Q4 results, which missed on EPS and came with guidance for negative Y/Y growth in Q1 at the midpoint…

… driven by normalization in the life sciences segment after a strong year and an exit from some low margin transportation work. While management still expects modest Y/Y growth in fiscal 2027…

… investors will likely wait for proof, with the current multiple sitting above the long-term average.

You might be interested in…

Disclaimer: Content on this site, including research reports, is provided by Bullpen Finance Inc. for informational purposes only and does not constitute investment advice. Bullpen Finance Inc. receives compensation from issuers for research coverage; such compensation does not influence opinions expressed. For complete disclosures, please see our Legal & Disclosures section.